Author:
Harsha Raj M.,Yashaswini B.,Rössler Jochen,Salimath Bharathi P.
Funder
Department of Biotechnology, New Delhi, India
University Grants Commission-Government of India
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Biochemistry, medical,Cell Biology,Clinical Biochemistry,Pharmaceutical Science,Pharmacology
Reference45 articles.
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer. GLOBOCAN 2008
2. Bonavida B, Khineche S, Huerta-Yepez S, Garbán H (2006) Therapeutic potential of nitric oxide in cancer. Drug Resist Updates 9(3):157–173
3. Almasan A, Ashkenazi A (2003) Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 14(3):337–348
4. Ashkenazi A, Pai R, Fong S, Leung S, Lawrence D, Marsters S et al (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Investig 104(2):155
5. Zhang L, Fang B (2005) Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther 12(3):228–237
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献